Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Looking for ways to monetize skills quickly? Turn your talents into cash and start earning today with these strategies.
17,417 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
A wave of commercial real estate loans is set to mature in 2026, testing lenders’ balance sheets and drawing Bitcoin ...
Investors weigh Amazon's Zoox-related progress against UPS's strategic shifts while oil volatility stirs the market. ...
Gas-price swings touch every part of the economy and your portfolio. This guide breaks down what's driving those move...
Federal officials order a Texas-based oil company to resume offshore California production under the Defense Producti...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Iranian tensions send energy prices higher as LNG and crude flows shift. A handful of U.S. energy stocks have surged ...
Airports face ongoing delays as spring travel returns. Enrolling in TSA PreCheck may help speed security lines for ti...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
2026 is testing DeFi trust with record hacks and stressed protocols. This report outlines how to choose a safe DeFi p...
Apyx Medical (APYX) 2026 is shaping up as a pivotal year for investors. This guide breaks down how to read the Q1 tra...